Uehara Y, Kawabata Y, Hirawa N, Takada S, Nagata T, Numabe A, Iwai J, Sugimoto T
Second Department of Medicine, University of Tokyo, Japan.
Am J Hypertens. 1993 Jun;6(6 Pt 1):463-72. doi: 10.1093/ajh/6.6.463.
Much interest in cicletanine, a novel antihypertensive drug, has grown because it uniquely stimulates prostacyclin (PGI2) production and may, thereby, provide further cardiovascular protection. We postulated that cicletanine may be an antioxidant, and assessed its ability to protect the kidney in Dahl salt-sensitive (Dahl S) rats on a high salt diet. Cicletanine eradicated in vitro a stable radical, DPPH, and decreased the lipid peroxidation both in rat brain homogenate and in a xanthine-xanthine oxidase (X-XOD) superoxide generating system. Furthermore, cicletanine attenuated the inhibition of PGI2 synthase activity by 15HPETE. However, cicletanine did not exhibit superoxide dismutase-like activity in X-XOD system, suggesting that it behaves primarily as a hydroxy radical scavenger. A 6 week cicletanine treatment reduced blood pressure in Dahl S rats fed a high salt diet, and ameliorated functional and morphological injury to the kidney. This attenuation of glomerular sclerosis correlated with the attenuation of lipid peroxidation in the kidney homogenate. These data indicate that cicletanine is an antioxidant that protects the kidney from salt-induced hypertension in Dahl salt-sensitive strain rats.
新型抗高血压药物西氯他宁引发了人们浓厚的兴趣,因为它能独特地刺激前列环素(PGI2)的生成,从而可能提供进一步的心血管保护作用。我们推测西氯他宁可作为一种抗氧化剂,并评估了其在高盐饮食的 Dahl 盐敏感(Dahl S)大鼠中保护肾脏的能力。西氯他宁在体外可清除稳定自由基 DPPH,并降低大鼠脑匀浆和黄嘌呤 - 黄嘌呤氧化酶(X - XOD)超氧阴离子生成系统中的脂质过氧化作用。此外,西氯他宁减弱了 15HPETE 对 PGI2 合酶活性的抑制作用。然而,西氯他宁在 X - XOD 系统中未表现出超氧化物歧化酶样活性,这表明它主要作为羟基自由基清除剂发挥作用。为期 6 周的西氯他宁治疗降低了高盐饮食的 Dahl S 大鼠的血压,并改善了肾脏的功能和形态损伤。肾小球硬化的减轻与肾匀浆中脂质过氧化作用的减轻相关。这些数据表明,西氯他宁是一种抗氧化剂,可保护 Dahl 盐敏感品系大鼠的肾脏免受盐诱导的高血压影响。